Monoclonal gammopathy-associated pure red cell aplasia Journal Article


Authors: Korde, N.; Zhang, Y.; Loeliger, K.; Poon, A.; Simakova, O.; Zingone, A.; Costello, R.; Childs, R.; Noel, P.; Silver, S.; Kwok, M.; Mo, C.; Young, N.; Landgren, O.; Sloand, E.; Maric, I.
Article Title: Monoclonal gammopathy-associated pure red cell aplasia
Abstract: Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24%) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
Keywords: myeloma; plasmacytosis; anaemia; monoclonal gammopathy of undetermined significance; pure red cell aplasia
Journal Title: British Journal of Haematology
Volume: 173
Issue: 6
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2016-06-01
Start Page: 876
End Page: 883
Language: English
DOI: 10.1111/bjh.14012
PUBMED: 26999424
PROVIDER: scopus
PMCID: PMC5549779
DOI/URL:
Notes: Article -- Export Date: 1 July 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carl Ola Landgren
    336 Landgren
  2. Neha Sanat Korde
    226 Korde